A Study Of AL101In Patients With Adenoid Cystic Carcinoma (ACC) Bearing Activating Notch Mutations
Clinical trial NCT03691207 · COMPLETED
Trial details
- NCT number
- NCT03691207
- Sponsor
- Ayala Pharmaceuticals, Inc,
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-14
- Primary completion
- 2022-07-15
- Enrollment
- 87
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.